Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Multiple Sclerosis


Study Dates:

Dates are flexible

Study Number

226702

Group

●  Multiple sclerosis

Compensation

Up to: $3,000

Gender

Male, Female, Smoker, Non-Smoker

Age

Additional Information

Travel costs may be covered. For more information, or to schedule a screening visit, please call 1-800-797-2448.

Details

Paid research study for people with relapsing forms of multiple sclerosis (MS).

The purpose of this study is to assess the safety, tolerability, and metabolism of an investigational drug, administered 4 times over a 6 month period, in patients with relapsing forms of multiple sclerosis (relapsing-remitting MS or secondary progressive MS), ages 18 to 60.

Eligible patients may be taking beta-interferons, Copaxone, Aubagio, Gilenya, Tecfidera, or no MS medication.

Participation involves 2 screening visits, 4 doses of study drug ~every 28 days (with optional inpatient admission), and 8 outpatient visits.